Not applicableStudy completedNCT01128439What this trial is testingStudy Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal DiseaseWho this might be right forInvasive Pneumococcal Disease Pfizer 1
Large-scale testing (Phase 3)Study completedNCT03921424What this trial is testingSafety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)Who this might be right forPneumococcal Infections Merck Sharp & Dohme LLC 407
Large-scale testing (Phase 3)Study completedNCT00918580What this trial is testingStudy Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell DiseaseWho this might be right forPneumococcal Conjugate Vaccine Pfizer 158
Large-scale testing (Phase 3)Not Yet RecruitingNCT07593924What this trial is testingClinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)Who this might be right forPneumococcal Infectious Diseases Sinovac Life Sciences Co., Ltd. 500
Post-approval studies (Phase 4)Study completedNCT00964769What this trial is testingStudy of Evaluation Indexes for Antibody Production in Sera After ImmunizationWho this might be right forAged Ewha Womans University 70
Not applicableActive Not RecruitingNCT01527591What this trial is testingPneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)Who this might be right forInfection in Solid Organ Transplant Recipients University of California, Los Angeles 17
Not applicableStudy completedNCT00889278What this trial is testingHigher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell TransplantationWho this might be right forLymphoma Dartmouth-Hitchcock Medical Center 30
Early research (Phase 1)Study completedNCT01033409What this trial is testingRecombinant Attenuated Salmonella Typhi Vaccine Vectors Producing Streptococcus Pneumoniae PspAWho this might be right forPneumonia Arizona State University 60
Not applicableUnknownNCT03102840What this trial is testingUnderstanding Pneumococcal Carriage and Disease 2017-2020Who this might be right forStreptococcus Pneumoniae InfectionStreptococcus Pneumoniae, Invasive DiseaseStreptococcal Pneumonia University of Oxford 2,400
Not applicableLooking for participantsNCT06760208What this trial is testingLearn More About Prevenar 20 Once it is Out in the Korean MarketWho this might be right forPneumococcal ImmunizationSafety Pfizer 660
Testing effectiveness (Phase 2)Study completedNCT03803202What this trial is testingA Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal VaccineWho this might be right forPneumonia, BacterialHealthy VolunteersPneumococcal Disease GlaxoSmithKline 630
Not applicableStudy completedNCT02742753What this trial is testingImpact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish ChildrenWho this might be right forAcute Otitis MediaOtitis Media GlaxoSmithKline 1
Large-scale testing (Phase 3)Active Not RecruitingNCT07284654What this trial is testingSafety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49Who this might be right forPneumococcal Vaccines Vaxcyte, Inc. 4,049
Early research (Phase 1)Study completedNCT02955160What this trial is testingA Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 YearsWho this might be right forPneumococcal Infections Pfizer 66
Large-scale testing (Phase 3)UnknownNCT05934890What this trial is testingEvaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13Who this might be right forPneumococcal Disease, Invasive Walvax Biotechnology Co., Ltd. 630
Post-approval studies (Phase 4)Study completedNCT01577771What this trial is testingImmunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina FasoWho this might be right forPneumococcal Infections Agence de Médecine Préventive, France 663
Large-scale testing (Phase 3)Study completedNCT00334334What this trial is testingSafety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.Who this might be right forInfections, Streptococcal GlaxoSmithKline 1,572
Testing effectiveness (Phase 2)Study completedNCT04398706What this trial is testingStudy of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsWho this might be right forPneumococcal ImmunisationDiphtheria ImmunisationTetanus Immunisation+8 more Sanofi Pasteur, a Sanofi Company 852
Early research (Phase 1)Ended earlyNCT03859687What this trial is testingTrial of Antibody Responses by Vitamin SupplementationWho this might be right forHealthy Participants St. Jude Children's Research Hospital 22
Testing effectiveness (Phase 2)Looking for participantsNCT02232191What this trial is testingImmunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury PatientsWho this might be right forAsplenia University of California, Davis 75